Clinical trial · Observational
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT03874871CI-TRIAL-00051120unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The real world based multi-cohorts study aims to evaluate the safety and effectiveness of function preserving gastrectomy including pylorus-preserving distal gastrectomy, proximal gastrectomy and wedge gastrectomy for T1 and T2 gastric cancer patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Gastrostomy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Function preserving gastrectomy | Procedure | — | UNRESOLVED |
| Standard gastrectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Function preserving gastrectomy
- description
- After baseline evaluation, a multidisciplinary discussion will be performed for the patients to choose the proper gastrectomy. For patients indicated for function preserving gastrectomy (including pylorus preserving gastrectomy, proximal gastrectomy, partial gastrectomy), they will receive the function preserving gastrectomy. After the surgery, a close follow up is performed.
- interventionNames
- Procedure: Function preserving gastrectomy
- label
- Standard gastrectomy
- description
- After baseline evaluation, a multidisciplinary discussion will be performed for the patients to choose the proper gastrectomy. For patients not indicated for function preserving gastrectomy, they will receive standard gastrectomy. After the surgery, a close follow up is performed.
- interventionNames
- Procedure: Standard gastrectomy
Primary outcomes (1)
- measure
- R0 resection rate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Karnofsky performance over 70% * Histologically proven gastric or gastroesophageal joint adenocarcinoma with clinical stage T1-2N0-3M0 * No severe comorbidity with estimated survival less than 5 years Exclusion Criteria: * pregnancy * Signs of distant metastases * received chemotherapy, radiotherapy, immune therapy * received gastrectomy * other malignant tumors within 5 years except for cured skin cancer and cervical caner in situ. * uncontrolled epilepsy, central nervus system disease or mental disease that affect the compliance of treatment and follow-up * severe heart disease * organ transplantation that needs immunosuppressor * emergency surgery due to hemorrhage, perforation and ileus of gastric cancer
References
Publications (0)
Data not yet available
No reference posted for this study.